ApoGen Biotechnologies Overview

  • Founded
  • 2014

Founded
  • Status
  • Out of Business

  • Employees
  • 10

Employees
  • Latest Deal Type
  • Out of Business

ApoGen Biotechnologies General Information

Description

Developer of advanced therapies intended to break drug resistance in cancer. The company develops therapies that target key drivers of ongoing deoxyribonucleic acid mutation and tumor evolution, enabling physicians to slow or stop cancer genome mutation.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 2815 Eastlake Avenue East
  • Suite 300
  • Seattle, WA 98102
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ApoGen Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 25-May-2021 0000 Completed Out of Business
3. Secondary Transaction - Private 0000 Completed Generating Revenue
2. Early Stage VC (Series A) 23-Aug-2018 $11M $11M 000.00 Completed Generating Revenue
1. Seed Round Completed Startup
To view ApoGen Biotechnologies’s complete valuation and funding history, request access »

ApoGen Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view ApoGen Biotechnologies’s complete cap table history, request access »

ApoGen Biotechnologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of advanced therapies intended to break drug resistance in cancer. The company develops therapies that target
Drug Discovery
Seattle, WA
10 As of 2021
0000
00000000 00 0000

000000

d tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000 000000000
San Carlos, CA
00 As of 0000
00000
000000000 00000

000000

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ApoGen Biotechnologies Competitors (73)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apexigen Formerly VC-backed San Carlos, CA 00 00000 000000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
00000000 000000000 Formerly VC-backed San Diego, CA 000 00000 0000000000.
0000000 0000000000 Venture Capital-Backed Maastricht, Netherlands 0 000.00 00000 00000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 73 competitors. Get the full list »

ApoGen Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial